Potential Benefits of Pre-emptive PGx Testing in Male Breast Cancer Patients

The objective is to report a case of recurrent breast cancer in a poor CYP2D6 metabolizer male patient on tamoxifen, and how pharmacogenomic (PGx) testing can play an important role in selecting appropriate adjuvant endocrine therapy. The case examined here is a 60-year-old white male diagnosed with...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Heather Randles (Autor), Nina Abraham (Autor), Michael J. Schuh (Autor)
Formato: Libro
Publicado: University of Minnesota Libraries Publishing, 2019-12-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible